Quince Therapeutics
QNCX
QNCX
52 hedge funds and large institutions have $594M invested in Quince Therapeutics in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
27% more funds holding
Funds holding: 41 → 52 (+11)
17.65% more ownership
Funds ownership: 21.79% → 39.43% (+18%)
Holders
52
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$24.2M | |
| 2 | +$17.6M | |
| 3 | +$10M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.02M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$5.81M |
Top Sellers
| 1 | -$6.9M | |
| 2 | -$1.25M | |
| 3 | -$1.1M | |
| 4 |
Millennium Management
New York
|
-$529K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$292K |